Abbott Laboratories (ABT) Q1 2026 (USD): Adj. EPS 1.15 (exp. 1.15), Revenue 11.2bln (exp. 11.00bln)

Abbott Laboratories reported Q1 adjusted EPS that met expectations while revenue slightly beat projections, suggesting stable demand in the health care sector.

Newsquawk StaffPublished On the live feed at 3 more headlines followed before this page went public
Newsquawk headlinesUTC

Lebanese President Aoun told US Secretary of State Rubio that he would not agree to talk to Netanyahu, Lebanese channel LBCI reports.

Charles Schwab (SCHW) Q1 2026 (USD): EPS 1.37 (exp. 1.35), Revenue 6.48bln (exp. 6.5bln)

Abbott Laboratories (ABT) Q1 2026 (USD): Adj. EPS 1.15 (exp. 1.15), Revenue 11.2bln (exp. 11.00bln)

US Secretary of State Rubio is expected to call Lebanese President Aoun and try to convince him to include Israel PM Netanyahu in the conversation,, via Al Araby

Riksbank Deputy Governor Jansson says uncertainty is high due to Middle East conflict

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.

Outlook

  • Q2 adj. EPS 1.25-1.32 (exp. 1.37).
  • FY26 adj. EPS 5.38-5.58 (exp. 5.61).
Context

However, the guidance for Q2 and FY26 is below consensus, indicating potential challenges ahead that could weigh on sentiment and future performance. This mixed outcome may lead traders to reassess the stock's valuation and expectations in the context of broader market dynamics.

Related headlines

The whole workspace, free to try.

Try it free